본문 바로가기
KERD
논문KCI 등재

전립선비대증 변증도구의 신뢰도 평가 및 IPSS, 요속과의 상관관계에 대한 탐색적 연구

A Pilot Study to Evaluate the Reliability of a Pattern Identification Tool for Benign Prostatic Hyperplasia and to Analyze Correlations between Pattern Identification Tools and International Prostate Symptom Score (IPSS) and Uroflowmetry

강위창|조충식|장은수|이은정|정인철|전천후|구지향
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2020.12|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제41권 제6호|pp. 1052-1065|DOI https://doi.org/10.22246/jikm.2020.41.6.1052

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

reliabilitybenign prostatic hyperplasiauroflowmetrypattern identification toolIPSS
주제분류한의학

초록

Objectives: To evaluate the reliability of a pattern identification tool for benign prostatic hyperplasia and to examine the relationship between pattern identification tool readings and IPSS and uroflowmetry. Methods: We analyzed 56 patients diagnosed with benign prostatic hyperplasia from December 27th, 2017 to December 26th, 2018 by two different Korean medical doctors and followed with a pattern identification tool and by IPSS and uroflowmetry. One week later, the patients were retested to analyze the reliability of the pattern identification tool, determined with the intraclass correlation coefficient (ICC) using the test-retest method. The correlation between IPSS and uroflowmetry was analyzed with the Pearson coefficient. Result: The reliability of the pattern identification tool for benign prostatic hyperplasia was evaluated as “poor agreement beyond chance” (ICC=0.349). The reliability of each pattern identification score was evaluated as “good” for Yang Deficiency of Kidney, Yin Deficiency of Kidney, Deficiency of Middle Qi, and Dampness-heat of Lower Energizer. The internal consistency was evaluated as “good” for Yang Deficiency of Kidney, Yin Deficiency of Kidney, and Dampness-heat of Lower Energizer, and as “excellent” for Deficiency of Middle Qi. The correlation between pattern identification and IPSS was evaluated as a “moderate positive correlation” for all pattern identifications. The average flow rate and maximum flow rate using uroflowmetry was evaluated with “moderate negative correlation” for Yang Deficiency of Kidney and Dampness-heat of Lower Energizer. Conclusion: The reliability of a pattern identification tool for benign prostatic hyperplasia was evaluated as “poor agreement beyond chance.” Further research is needed. Objectives: To evaluate the reliability of a pattern identification tool for benign prostatic hyperplasia and to examine the relationship between pattern identification tool readings and IPSS and uroflowmetry. Methods: We analyzed 56 patients diagnosed with benign prostatic hyperplasia from December 27th, 2017 to December 26th, 2018 by two different Korean medical doctors and followed with a pattern identification tool and by IPSS and uroflowmetry. One week later, the patients were retested to analyze the reliability of the pattern identification tool, determined with the intraclass correlation coefficient (ICC) using the test-retest method. The correlation between IPSS and uroflowmetry was analyzed with the Pearson coefficient. Result: The reliability of the pattern identification tool for benign prostatic hyperplasia was evaluated as “poor agreement beyond chance” (ICC=0.349). The reliability of each pattern identification score was evaluated as “good” for Yang Deficiency of Kidney, Yin Deficiency of Kidney, Deficiency of Middle Qi, and Dampness-heat of Lower Energizer. The internal consistency was evaluated as “good” for Yang Deficiency of Kidney, Yin Deficiency of Kidney, and Dampness-heat of Lower Energizer, and as “excellent” for Deficiency of Middle Qi. The correlation between pattern identification and IPSS was evaluated as a “moderate positive correlation” for all pattern identifications. The average flow rate and maximum flow rate using uroflowmetry was evaluated with “moderate negative correlation” for Yang Deficiency of Kidney and Dampness-heat of Lower Energizer. Conclusion: The reliability of a pattern identification tool for benign prostatic hyperplasia was evaluated as “poor agreement beyond chance.” Further research is needed.

Abstract

Objectives: To evaluate the reliability of a pattern identification tool for benign prostatic hyperplasia and to examine the relationship between pattern identification tool readings and IPSS and uroflowmetry. Methods: We analyzed 56 patients diagnosed with benign prostatic hyperplasia from December 27th, 2017 to December 26th, 2018 by two different Korean medical doctors and followed with a pattern identification tool and by IPSS and uroflowmetry. One week later, the patients were retested to analyze the reliability of the pattern identification tool, determined with the intraclass correlation coefficient (ICC) using the test-retest method. The correlation between IPSS and uroflowmetry was analyzed with the Pearson coefficient. Result: The reliability of the pattern identification tool for benign prostatic hyperplasia was evaluated as “poor agreement beyond chance” (ICC=0.349). The reliability of each pattern identification score was evaluated as “good” for Yang Deficiency of Kidney, Yin Deficiency of Kidney, Deficiency of Middle Qi, and Dampness-heat of Lower Energizer. The internal consistency was evaluated as “good” for Yang Deficiency of Kidney, Yin Deficiency of Kidney, and Dampness-heat of Lower Energizer, and as “excellent” for Deficiency of Middle Qi. The correlation between pattern identification and IPSS was evaluated as a “moderate positive correlation” for all pattern identifications. The average flow rate and maximum flow rate using uroflowmetry was evaluated with “moderate negative correlation” for Yang Deficiency of Kidney and Dampness-heat of Lower Energizer. Conclusion: The reliability of a pattern identification tool for benign prostatic hyperplasia was evaluated as “poor agreement beyond chance.” Further research is needed.

참고문헌 (31)

  1. Chughtai B, "Benign prostatic hyperplasia", Nat Rev Dis Prim, 2(1), pp.1~15 (2016)
  2. AUA Practice Guidelines Committee, "AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1:Diagnosis and treatment recommendations", J Urol, 170(2), pp.530~547 (2003)
  3. Eum HS, "Clinical Report on a Patient with Benign Prostatic Hyperplasia diagnosed as the Deficiency of Yang of the Kidney", J Korea Inst Orient Med informatics, 10(2), pp.8~16 (2004)
  4. Berle CA, "A novel approach to evaluate traditional Chinese medicine treatment outcomes using pattern identification", J Altern Complement Med, 16(4), pp.357~367 (2010)
  5. 황미니, "기능성소화불량의 식적설문지 개발과 신뢰도 및 타당도 검정", 대한한방내과학회지, 40(3), pp.390~408 (2019), 대한한방내과학회[DOI]
  6. 오승준, "퇴행성 무릎관절염 변증도구의 신뢰도 평가 및 무릎 ROM, VAS, WOMAC과의 상관관계에 대한 탐색적 연구", 한방재활의학과학회지, 29(3), pp.113~128 (2019), 한방재활의학과학회[DOI]
  7. 이헌수, "우울증 변증도구의 신뢰도, 타당도 평가", 동의신경정신과학회지, 26(4), pp.407~416 (2015), 대한한방신경정신과학회
  8. 이헌수, "화병 한의 평가도구의 신뢰도, 타당도 평가", 동의신경정신과학회지, 25(4), pp.351~358 (2014), 대한한방신경정신과학회
  9. 정호영, "전립선비대증 변증도구 개발 기초 연구", 대한한방내과학회지, 38(3), pp.301~318 (2017), 대한한방내과학회
  10. Hyeon Ju Kim, "Relationship Between Prostate Volume and Lower Urinary Tract Symptom in Health Checkup Subjects", Journal of Urologic Oncology, 18(1), pp.53~60 (2020), 대한비뇨기종양학회[DOI]
  11. Madersbacher S, "Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement : a mini-review", Gerontology, 65(5), pp.458~464 (2019)
  12. McVary KT, "Update on AUA guideline on the management of benign prostatic hyperplasia", J Urol, 185(5), pp.1793~1803 (2011)
  13. Dvorkin L, "Herbs for benign prostatic hyperplasia", Ann Pharmacother, 36(9), pp.1443~1452 (2002)
  14. Vuichoud C, "Benign prostatic hyperplasia:epidemiology, economics and evaluation", Can J Urol, 22(Suppl 1), pp.1~6 (2015)
  15. 배인숙, "양성 전립선 비대증 유발 쥐에 단미 한약재가 미치는 영향에 관한 연구 분석", 대한한방내과학회지, 39(4), pp.592~604 (2018), 대한한방내과학회
  16. 배고은, "전립선 비대증에 대한 뜸치료의 효과 : 체계적 문헌고찰과 메타분석", 대한한방내과학회지, 39(3), pp.372~388 (2018), 대한한방내과학회
  17. 박성환, "전침 및 봉약침치료를 시술한 양성전립선비대증 환자의 임상증상개선에 대한 후향적 단면연구", 대한한방내과학회지, 31(3), pp.437~447 (2010), 대한한방내과학회
  18. Zhang W, "Acupuncture for benign prostatic hyperplasia : A systematic review and meta-analysis", PLoS One, 12(4), pp.e0174586~ (2017)
  19. Ma CH, "Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia : systematic review of randomized controlled trials", Asian J Androl, 15(4), pp.471~482 (2013)
  20. Wang Y, "Electroacupuncture for moderate and severe benign prostatic hyperplasia : a randomized controlled trial", PLoS One, 8(4), pp.e59449~ (2013)
  21. Chen WF, "Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-β", Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats, 2019, pp.2019, 6281819~
  22. Cai H, "The Effect of Xialiqi capsule on testosterone-induced benign prostatic hyperplasia in rats", Evidence-Based Complement Altern Med, 2018 (2018)
  23. Smith F, "Research Methods in Pharmacy Practice", pp.43~84 (2002), Pharmaceutical Press
  24. Fleiss JL, "Statistical Methods for Rates and Proportions" (2003), John wiley &sons
  25. Koo TK, "A guideline of selecting and reporting intraclass correlation coefficients for reliability research", J Chiropr Med, 15(2), pp.155~163 (2016)
  26. Knapp TR, "Coefficient alpha : conceptualizations and anomalies", Res Nurs Health, 14(6), pp.457~460 (1991)
  27. Homma Y, "Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score", Int J Urol, 4(1), pp.40~46 (1997)
  28. Dancey CP, "Statistics without Maths for Psychology", pp.175~ (2011), Prentice Hall
  29. Kuo HC, "Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry", Urology, 54(1), pp.90~96 (1999)
  30. El Din KE, "Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score", Urology, 48(3), pp.393~397 (1996)
  31. 남성욱, "기능성소화불량에서 胃氣虛證과 복부초음파로 측정한 위 배출능과의 상관성 분석", 대한한방내과학회지, 39(3), pp.405~425 (2018), 대한한방내과학회

관련 논문AI추천

전립선비대증 변증도구 개발 기초 연구박양춘, 이지윤, 정인철, 정호영, 조충식대한한방내과학회 · 대한한방내과학회지2017 · 제38권 제3호전립선증식증(Benign Prostatic Hyperplasia)의 한의 임상 진료 현황 조사를 위한 온라인 설문 조사백지수, 신선미, 조충식대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제4호전립선비대증에 대한 치료의 근거 : 임상논문을 중심으로김대건, 김소연, 박성하, 윤한성, 이지혜, 조한신, 최준용, 한창우한의병리학회 · 동의생리병리학회지2015 · 제29권 제5호전침 및 봉약침치료를 시술한 양성전립선비대증 환자의 임상증상개선에 대한 후향적 단면연구강지석, 박성환, 안세영, 안영민, 이병철, 이혜정, 한수련대한한방내과학회 · 대한한방내과학회지2010 · 제31권 제3호전립선 비대증에 대한 뜸치료의 효과 : 체계적 문헌고찰과 메타분석이인, 권정남, 김소연, 박성하, 배고은, 윤영주, 이승환, 최준용, 한창우, 홍진우대한한방내과학회 · 대한한방내과학회지2018 · 제39권 제3호급성 요폐 및 하부요로증상의 少陽人 六味地黃湯加減方 치험 1례김동영, 김원영, 오지연, 이여경, 임은철, 조승완, 홍승효사상체질면역의학회 · 사상체질면역의학회지2020 · 제32권 제2호

이 간행물의 다른 논문 (30건)

한약복용이 간기능에 미치는 영향 : 국내 문헌에 대한 체계적 고찰제유란, 박상은, 김경림, 하다정pp. 933-946파킨슨병 환자의 통증에 대한 한의치료의 효과 : 후향적 연구김서영, 박성욱, 권승원, 정혜선, 임태빈, 정우상, 박정미, 조승연, 문상관, 진철, 고창남, 김하리pp. 947-958한약 임상시험의 특성 : 질병관리본부 임상연구정보서비스(CRIS)를 중심으로전선우, 조희근, 정창운pp. 959-966오가피청혈플러스가 NF-κB 및 MAPKs 신호전달체계와 혈관부착인자 등에 미치는 영향배지은, 유호룡, 김윤식, 최규철, 설인찬, 이지원pp. 967-983임상한의학 실시간 비대면교육의 평가를 위한 설문조사 연구양승보pp. 984-992
원문 보기